Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
M F Linton, … , M R Wardell, S G Young
M F Linton, … , M R Wardell, S G Young
Published July 1, 1991
Citation Information: J Clin Invest. 1991;88(1):270-281. https://doi.org/10.1172/JCI115288.
View: Text | PDF
Research Article Article has an altmetric score of 6

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

  • Text
  • PDF
Abstract

Apolipoprotein (apo) E and the two B apolipoproteins, apoB48 and apoB100, are important proteins in human lipoprotein metabolism. Commonly occurring polymorphisms in the genes for apoE and apoB result in amino acid substitutions that produce readily detectable phenotypic differences in these proteins. We studied changes in apoE and apoB phenotypes before and after liver transplantation to gain new insights into apolipoprotein physiology. In all 29 patients that we studied, the postoperative serum apoE phenotype of the recipient, as assessed by isoelectric focusing, converted virtually completely to that of the donor, providing evidence that greater than 90% of the apoE in the plasma is synthesized by the liver. In contrast, the cerebrospinal fluid apoE phenotype did not change to the donor's phenotype after liver transplantation, indicating that most of the apoE in CSF cannot be derived from the plasma pool and therefore must be synthesized locally. The apoB100 phenotype (assessed with immunoassays using monoclonal antibody MB19, an antibody that detects a two-allele polymorphism in apoB) invariably converted to the phenotype of the donor. In four normolipidemic patients, we determined the MB19 phenotype of both the apoB100 and apoB48 in the "chylomicron fraction" isolated from plasma 3 h after a fat-rich meal. Interestingly, the apoB100 in the chylomicron fraction invariably had the phenotype of the donor, indicating that the vast majority of the large, triglyceride-rich apoB100-containing lipoproteins that appear in the plasma after a fat-rich meal are actually VLDL of hepatic origin. The MB19 phenotype of the apoB48 in the plasma chylomicron fraction did not change after liver transplantation, indicating that almost all of the apoB48 in plasma chylomicrons is derived from the intestine. These results were consistent with our immunocytochemical studies on intestinal biopsy specimens of organ donors; using apoB-specific monoclonal antibodies, we found evidence for apoB48, but not apoB100, in donor intestinal biopsy specimens.

Authors

M F Linton, R Gish, S T Hubl, E Bütler, C Esquivel, W I Bry, J K Boyles, M R Wardell, S G Young

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1986 Total
Citations: 3 9 14 17 11 16 9 5 7 9 10 12 10 8 11 12 8 4 5 5 5 9 10 8 10 10 13 12 6 4 7 2 4 3 2 290
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2010 (12)

Title and authors Publication Year
Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis
RM Uranga, JN Keller
Current Gerontology and Geriatrics Research 2010
Apolipoproteins in the brain: implications for neurological and psychiatric disorders
DA Elliott, CS Weickert, B Garner
Clinical Lipidology 2010
Traumatic Brain Injury Exacerbates Neurodegenerative Pathology: Improvement with an Apolipoprotein E-Based Therapeutic
DT Laskowitz, P Song, H Wang, B Mace, PM Sullivan, MP Vitek, HN Dawson
Journal of Neurotrauma 2010
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis
H Zhang, J Wu, J Zhu
Journal of biomedicine & biotechnology 2010
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis
HL Zhang, J Wu, J Zhu
Clinical & developmental immunology 2010
Comment on: Cerebrospinal fluid apolipoprotein E concentration decreases after seizure
J Wu, P Liu, J Lei, HL Zhang
Seizure 2010
Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid
P Khumsupan, R Ramirez, D Khumsupan, V Narayanaswami
Biochimica et Biophysica Acta 2010
COG1410, an Apolipoprotein E-based Peptide, Improves Cognitive Performance and Reduces Cortical Loss Following Moderate Fluid Percussion Injury in the Rat
NA Kaufman, JE Beare, AA Tan, MP Vitek, SE McKenna, MR Hoane
Behavioural Brain Research 2010
Lipoprotein remodelling in the periphery: A model for the brain?
C Yu, KL Youmans, MJ LaDu
Biochimica et Biophysica Acta 2010
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
MR Farlow
Alzheimer's research & therapy 2010
Novel Genetic Mutation in Apolipoprotein E2 Homozygosis and Its Implication in Organ Donation: A Case Report
N Cautero, FD Benedetto, ND Ruvo, R Montalti, GP Guerrini, R Ballarin, M Spaggiari, N Smerieri, MG Blasiis, G Rompianesi, RM Iemmolo, M Marino, M Bertolotti, S Zivieri, GE Gerunda
Transplantation Proceedings 2010
Pyrene Fluorescence Analysis Offers New Insights into the Conformation of the Lipoprotein-Binding Domain of Human Apolipoprotein E
AB Patel, P Khumsupan, V Narayanaswami
Biochemistry 2010

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
147 readers on Mendeley
See more details